Letter by Cheen Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".

Letter by Cheen Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States". Circulation. 2019 Mar 19;139(12):1561-1562 Authors: Cheen MHH PMID: 30883225 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30883225?dopt=Abstract

Source: Circulation - March 18, 2019 Category: Cardiology Authors: Cheen MHH Tags: Circulation Source Type: research

More News: Atrial Fibrillation | Cardiology | Urology & Nephrology | USA Health